IND Export Requirements Simplified In FDA Final Rule
Executive Summary
A final rule issued by FDA simplifying requirements for investigational new drug exports prohibits transshipment of drugs from a "listed" country to an "unlisted" country where the drug does not have market authorization, but otherwise includes few changes over the proposed rule issued in 2002